Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.
Press releases published on July 15, 2025

CareSource Georgia collaborates with Georgia Family Connection Partnership to improve maternal and infant health across rural Georgia
ATLANTA, July 15, 2025 (GLOBE NEWSWIRE) -- CareSource Georgia, a nonprofit managed care organization, has announced a collaboration with Georgia Family Connection Partnership (GaFCP), an organization that brings local and state-level leaders, and resources …

AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies
BERWYN, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, distinguishes itself as the partner of choice for rare disease pharmaceutical manufacturers, …

Aegle Therapeutics Names Industry Veteran Scott Braunstein, M.D. as Chairman of the Board
BOSTON, July 15, 2025 (GLOBE NEWSWIRE) -- Aegle Therapeutics, a clinical-stage dermatology-focused biopharmaceutical company developing novel therapies for those living with rare and severe skin diseases, today announced the appointment of Scott Braunstein …

Just Like Family Launches Compassionate Home Care Services in Newmarket, Aurora, and Bradford
Newmarket, ON , July 15, 2025 (GLOBE NEWSWIRE) -- Just Like Family Home Care, a trusted Canadian company, is proud to announce the launch of its services in Newmarket, Aurora, and Bradford. This local family-run business, led by Jason and Sandra Durocher, …

Chalk River Laboratories Becomes First GLP-Certified Laboratory in Canada to Offer Pre-Clinical Radiopharmaceutical Studies
CHALK RIVER, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that the Chalk River Laboratories has become the first Good Laboratory …

Les Laboratoires de Chalk River deviennent les premiers laboratoires certifiés BPL au Canada à offrir des études radiopharmaceutiques précliniques
CHALK RIVER, Ontario, 15 juill. 2025 (GLOBE NEWSWIRE) -- Les Laboratoires nucléaires canadiens (LNC), la principale organisation de science et de technologie nucléaires au Canada, ont le plaisir d’annoncer que les Laboratoires de Chalk River sont devenus …

SRx Health Solutions Announces Management and Board Changes
TAMPA, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the appointment of current President, Kent Cunningham, as CEO, and current CEO, …

Trio of Prestigious Awards Honors Drug-Free Chronic Constipation Treatment: Vibrant®
Austin, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Vibrant Gastro, inventor of the groundbreaking Vibrant® System, a non-pharmaceutical treatment for chronic idiopathic constipation, today announced it has been honored with a series of awards and recognitions …

Piston Bio Receives Endorsement from Leading Oncologists for its Tumor Antigen-Inducing Therapeutic
MORRISTOWN, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- Piston Bio LLC, a biotechnology company developing both small molecules and biologics for the treatment of cancer, today announced that its scientific advisors have endorsed the potential of its next- …

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026
MARIETTA, Ga., July 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”) proposal. “We …

60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
WASHINGTON, July 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company” or “60 Degrees”) (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the pricing of a …

Circuit Clinical Partners with Western New York Medical to Expand Access to Clinical Trials in Buffalo
BUFFALO, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Circuit Clinical, is proud to announce a new partnership with Western New York Medical (WNY Medical) to bring clinical trials directly to patients in central Buffalo. This collaboration is more than a …

Award-Winning Holixer from Natural Remedies Delivers Clinically Proven Sleep Support
BANGALORE, India, July 15, 2025 (GLOBE NEWSWIRE) -- With rising nighttime temperatures disrupting sleep across the United States, clinical research shows Holixer™, a patented and clinically validated extract from Natural Remedies, derived from holy basil ( …

Evestia Clinical to merge with Atlantic Research Group
Kester Capital-backed Evestia Clinical merges with US-based Atlantic Research Group (ARG) to create a leading independent global specialist CRO in fast-growing markets The merger delivers on Evestia Clinical’s strategy of targeted growth through the …

Myriad Genetics Earns 2025 Great Place To Work Certification™
SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has received the Great Place to Work Certification for the third year in a row. The …

Beverly Hills MD Launches Metabolic Reset: A Revolutionary Weight Management Support Formula
BEVERLY HILLS, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Beverly Hills MD®, founded by renowned cosmetic surgeons Dr. John Layke and Dr. Payman Danielpour, is proud to announce the launch of Beverly Hills MD Metabolic Reset, a cutting-edge supplement …

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
SAN JOSE, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has …

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
$10 million securities purchase agreement provides efficient and flexible funding in support of strategic multi-million dollar growth initiatives Discussions underway to expand adoption of ChemoFx in the U.S. and accelerate initial launch in Europe …

Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
CANTON, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices
VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has directed …